4.7 Article

Single-Nucleotide Variations, Insertions/Deletions and Copy Number Variations in Myelodysplastic Syndrome during Disease Progression Revealed by a Single-Cell DNA Sequencing Platform

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Hematology

Management of patients with higher-risk myelodysplastic syndromes after failure of hypomethylating agents: What is on the horizon?

Jan Philipp Bewersdorf et al.

Summary: Hypomethylating agents AZA and DAC are standard frontline treatments for high-risk MDS, but often lead to unsatisfactory responses and short survival durations, known as HMA failure. While salvage therapies like novel HMAs and ICPIs have shown mixed results in MDS patients with HMA failure, the development of targeted agents like venetoclax and ICPIs has demonstrated activity in combination with HMA in frontline treatment. However, limited clinical testing of these agents post HMA failure and poorly defined biology of HMA failure highlight the need for optimization of frontline therapy and development of more effective salvage therapies.

BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2021)

Article Oncology

Personalized Prediction Model to Risk Stratify Patients With Myelodysplastic Syndromes

Aziz Nazha et al.

Summary: This study developed a personalized prediction model for MDS patients using machine learning techniques and incorporating clinical and genomic data, which showed superior performance in predicting survival and leukemia transformation probabilities compared to established models. The model was validated in external cohorts, demonstrating its potential for dynamic and accurate prognostic predictions at different time points in a patient's disease course.

JOURNAL OF CLINICAL ONCOLOGY (2021)

Article Oncology

Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes

Matteo Bersanelli et al.

Summary: The study identified eight distinct subgroups of MDS based on specific genomic features, each with different prognostic outcomes. By integrating clinical and genomic variables, a novel prognostic model was developed to provide personalized survival predictions for MDS patients. This model significantly improved the accuracy of current prognostic tools and has the potential to revolutionize disease classification and prognosis in the future.

JOURNAL OF CLINICAL ONCOLOGY (2021)

Review Oncology

Resistance to venetoclax and hypomethylating agents in acute myeloid leukemia

Antoine N. Saliba et al.

Summary: This review article discusses the mechanisms of resistance to venetoclax and HMA in AML treatment, as well as potential therapeutic strategies to overcome this resistance. Understanding resistance mechanisms is crucial for maximizing the benefits of novel drugs, identifying new therapeutic targets, defining potential prognostic markers, and avoiding treatment failure in AML.

CANCER DRUG RESISTANCE (2021)

Article Multidisciplinary Sciences

The mutational constraint spectrum quantified from variation in 141,456 humans

Konrad J. Karczewski et al.

NATURE (2020)

Article Hematology

Myelodysplastic syndromes: 2021 update on diagnosis, risk stratification and management

Guillermo Garcia-Manero et al.

AMERICAN JOURNAL OF HEMATOLOGY (2020)

Review Biochemistry & Molecular Biology

Mechanisms Underlying Resistance to FLT3 Inhibitors in Acute Myeloid Leukemia

Motoki Eguchi et al.

BIOMEDICINES (2020)

Review Hematology

Treatment of MDS

Uwe Platzbecker

Article Biochemical Research Methods

VarSome: the human genomic variant search engine

Christos Kopanos et al.

BIOINFORMATICS (2019)

Review Hematology

How I treat MDS after hypomethylating agent failure

Valeria Santini

Article Biochemistry & Molecular Biology

ClinVar: improving access to variant interpretations and supporting evidence

Melissa J. Landrum et al.

NUCLEIC ACIDS RESEARCH (2018)

Review Biochemistry & Molecular Biology

Molecular and Cellular Mechanisms of Myelodysplastic Syndrome: Implications on Targeted Therapy

Harinder Gill et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)

Article Medicine, Research & Experimental

Specific molecular signatures predict decitabine response in chronic myelomonocytic leukemia

Kristen Meldi et al.

JOURNAL OF CLINICAL INVESTIGATION (2015)

Article Biochemical Research Methods

DANN: a deep learning approach for annotating the pathogenicity of genetic variants

Daniel Quang et al.

BIOINFORMATICS (2015)

Article Biochemical Research Methods

Trimmomatic: a flexible trimmer for Illumina sequence data

Anthony M. Bolger et al.

BIOINFORMATICS (2014)

Article Biochemistry & Molecular Biology

VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing

Daniel C. Koboldt et al.

GENOME RESEARCH (2012)

Article Medicine, General & Internal

Clonal Architecture of Secondary Acute Myeloid Leukemia

Matthew J. Walter et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Article Biochemistry & Molecular Biology

ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data

Kai Wang et al.

NUCLEIC ACIDS RESEARCH (2010)

Article Biochemical Research Methods

Fast and accurate short read alignment with Burrows-Wheeler transform

Heng Li et al.

BIOINFORMATICS (2009)

Article Biochemistry & Molecular Biology

dbSNP: a database of single nucleotide polymorphisms

EM Smigielski et al.

NUCLEIC ACIDS RESEARCH (2000)